MIT develops a new vaccine offering protection against SARS-CoV-2 variants and related sarbecoviruses, addressing future pandemic threats.

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...

The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12 ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

InnoCare Pharma (HKEX: 09969; SSE: 688428) and KeyMed Biosciences (HKEX: 02162) today announced that the two companies, ...

The two positive cases are among 31 samples tested, and officials are considering use of antivirals and experimental vaccine.

A multi-institutional team of investigators have developed a catalog of transcription factor binding sites that regulate gene expression across the genome, according to a recent study published in ...

In the region's other developments, Sierra Leone reported more cases, with the first two linked to the clade 2 global strain.